Study of the Expression on the CD44v5 Adhesion Molecule in Invasive Lobular Carcinomas of the Breast. Association between Negativity and Cellular S-Phase Fraction >7%

Catterall J.B. , Gardner M.J. , Turner G.A. Hyaluronic acid and cell adhesion and metastases. Cancer J 1995; 8: 320–4.

Herrera Gayol A. , Jothy S. CD44 modulates Hs578T human breast cancer cell adhesion, migration and invasiveness. Exp Mol Pathol 1999; 66: 99–108.

Sinn H.P. , Heider K.H. , Skroch-Angel P. Human mammary carcinomas express homologues fo rat metastasis-associated variants of CD44. Breast Cancer Res Treat 1995; 36: 307–13.

Knupfer M.M. , Poppenborg H. , Hotfilder M. , Kuhnel K. , Wolff J.E. , Domula M. CD44 expression and hyaluronic acid binding of malignant glioma cells. Clin Exp Metastasis 1999; 17: 71–6.

Bankfalvi A. , Terpe H.J. , Breukelmann D. Gains and losses of CD44 expression during breast carcinogenesis and tumor progression. Histopathol 1998; 33: 107–11.

Heffer L. , Tempfer C. , Haeusler G. Cytosol concentrations of CD44 isoforms in breast cancer tissue. Int J Cancer 1998; 79: 541–5.

Nuñez M.I. , Arias J. , del Rio M.C. Cell surface CD44v5 levels correlate with progesterone receptors and a tumor size >2 cm in infiltrating ductal carcinomas of the breast. Int J Biol Markers 1996; 11: 220–2.

Tempfer C. , Losch A. , Heinzl H. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7–8 in human breast cancer. Eur J Cancer 1996; 32: 2023–5.

Haagensen C.D. , Bodian C. , Haagensen D.E. Breast carcinoma: risk and detection. Philadelphia: WB Saunders, 1981.

Ruibal A. , Fernández Llana B. , Alba A. , Nuñez M.I. , Martínes M.I. , Allende M.T. Cyfra 21.2 cytosolic levels in breast diseases; Correlation with other clinical and biological parameters. Int J Biol Markers 1996; 11: 90–2.